{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T03:09:35Z","timestamp":1789873775679,"version":"4.0.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82402695, 82372313, 82272390, 82102482, 82072371"],"award-info":[{"award-number":["82402695, 82372313, 82272390, 82102482, 82072371"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82402695, 82372313, 82272390, 82102482, 82072371"],"award-info":[{"award-number":["82402695, 82372313, 82272390, 82102482, 82072371"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82402695, 82372313, 82272390, 82102482, 82072371"],"award-info":[{"award-number":["82402695, 82372313, 82272390, 82102482, 82072371"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82402695, 82372313, 82272390, 82102482, 82072371"],"award-info":[{"award-number":["82402695, 82372313, 82272390, 82102482, 82072371"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82402695, 82372313, 82272390, 82102482, 82072371"],"award-info":[{"award-number":["82402695, 82372313, 82272390, 82102482, 82072371"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82402695, 82372313, 82272390, 82102482, 82072371"],"award-info":[{"award-number":["82402695, 82372313, 82272390, 82102482, 82072371"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82402695, 82372313, 82272390, 82102482, 82072371"],"award-info":[{"award-number":["82402695, 82372313, 82272390, 82102482, 82072371"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82402695, 82372313, 82272390, 82102482, 82072371"],"award-info":[{"award-number":["82402695, 82372313, 82272390, 82102482, 82072371"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82402695, 82372313, 82272390, 82102482, 82072371"],"award-info":[{"award-number":["82402695, 82372313, 82272390, 82102482, 82072371"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-025-01673-4","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T04:18:06Z","timestamp":1752725886000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["DEK facilitates bortezomib resistance of multiple myeloma by modulating ferroptosis"],"prefix":"10.1007","volume":"25","author":[{"given":"Huiquan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiafeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hefei","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Kun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiying","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,17]]},"reference":[{"issue":"6","key":"1673_CR1","first-page":"422","volume":"64","author":"G Bianchi","year":"2014","unstructured":"Bianchi G, Anderson KC. Understanding biology to tackle the disease: Multiple myeloma from bench to bedside, and back. CA Cancer J Clin. 2014;64(6):422\u201344.","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"1673_CR2","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nrc.2017.63","volume":"17","author":"C Pawlyn","year":"2017","unstructured":"Pawlyn C, Morgan GJ. Evolutionary biology of high-risk multiple myeloma. Nat Rev Cancer. 2017;17(9):543\u201356.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"1673_CR3","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1038\/s41375-020-01033-z","volume":"35","author":"C Gu","year":"2021","unstructured":"Gu C, Lu T, Wang W, et al. RFWD2 induces cellular proliferation and selective proteasome inhibitor resistance by mediating P27 ubiquitination in multiple myeloma. Leukemia. 2021;35(6):1803\u20137.","journal-title":"Leukemia"},{"issue":"1","key":"1673_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/bjh.15210","volume":"182","author":"CT Wallington-Beddoe","year":"2018","unstructured":"Wallington-Beddoe CT, Sobieraj-Teague M, Kuss BJ, et al. Resistance to proteasome inhibitors and other targeted therapies in myeloma. Br J Haematol. 2018;182(1):11\u201328.","journal-title":"Br J Haematol"},{"issue":"12","key":"1673_CR5","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.3390\/cells10123464","volume":"10","author":"N Nikesitch","year":"2021","unstructured":"Nikesitch N, Rebeiro P, Ho LL, et al. The role of chaperone-mediated autophagy in bortezomib resistant multiple myeloma. Cells. 2021;10(12):3464.","journal-title":"Cells"},{"issue":"1","key":"1673_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3390\/ph16010111","volume":"16","author":"G Kozalak","year":"2023","unstructured":"Kozalak G, Butun I, Toyran E, et al. Review on bortezomib resistance in multiple myeloma and potential role of emerging technologies. Pharmaceuticals (Basel). 2023;16(1):111.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"6","key":"1673_CR7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3892\/or.2022.8322","volume":"47","author":"B Liu","year":"2022","unstructured":"Liu B, Sun YL, Zhang Y, et al. DEK modulates both expression and alternative splicing of cancer-related genes. Oncol Rep. 2022;47(6):111.","journal-title":"Oncol Rep"},{"issue":"1","key":"1673_CR8","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3390\/cells8010076","volume":"8","author":"A Mendes","year":"2019","unstructured":"Mendes A, Fahrenkrog B. NUP214 in Leukemia: it\u2019s more than transport. Cells. 2019;8(1):76.","journal-title":"Cells"},{"issue":"22","key":"1673_CR9","doi-asserted-by":"publisher","first-page":"5689","DOI":"10.3390\/ijms20225689","volume":"20","author":"KF Lee","year":"2019","unstructured":"Lee KF, Tsai MM, Tsai CY, et al. DEK is a potential biomarker associated with malignant phenotype in gastric cancer tissues and plasma. Int J Mol Sci. 2019;20(22):5689.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1673_CR10","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1172\/JCI127460","volume":"129","author":"ML Capitano","year":"2019","unstructured":"Capitano ML, Mor-Vaknin N, Saha AK, et al. Secreted nuclear protein DEK regulates hematopoiesis through CXCR2 signaling. J Clin Invest. 2019;129(6):2555\u201370.","journal-title":"J Clin Invest"},{"issue":"4","key":"1673_CR11","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/MOH.0000000000000344","volume":"24","author":"ML Capitano","year":"2017","unstructured":"Capitano ML, Broxmeyer HE. A role for intracellular and extracellular DEK in regulating hematopoiesis. Curr Opin Hematol. 2017;24(4):300\u20136.","journal-title":"Curr Opin Hematol"},{"issue":"10","key":"1673_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1010463","volume":"18","author":"C Chiriches","year":"2022","unstructured":"Chiriches C, Nicolaisen N, Wieske M, et al. Understanding a high-risk acute myeloid leukemia by analyzing the interactome of its major driver mutation. PLoS Genet. 2022;18(10): e1010463.","journal-title":"PLoS Genet"},{"issue":"2","key":"1673_CR13","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/s41375-023-02118-1","volume":"38","author":"S Potluri","year":"2024","unstructured":"Potluri S, Kellaway SG, Coleman DJL, et al. Gene regulation in t(6;9) DEK::NUP214 acute myeloid leukemia resembles that of FLT3-ITD\/NPM1 acute myeloid leukemia but with an altered HOX\/MEIS axis. Leukemia. 2024;38(2):403\u20137.","journal-title":"Leukemia"},{"issue":"12","key":"1673_CR14","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1097\/PAS.0000000000001741","volume":"45","author":"LM Rooper","year":"2021","unstructured":"Rooper LM, Agaimy A, Dickson BC, et al. DEK-AFF2 carcinoma of the sinonasal region and skull base: detailed clinicopathologic characterization of a distinctive entity. Am J Surg Pathol. 2021;45(12):1682\u201393.","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"1673_CR15","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/PAP.0000000000000376","volume":"30","author":"K Ruangritchankul","year":"2023","unstructured":"Ruangritchankul K, Sandison A. DEK::AFF2 fusion carcinomas of head and neck. Adv Anat Pathol. 2023;30(2):86\u201394.","journal-title":"Adv Anat Pathol"},{"key":"1673_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1746-1596-9-67","volume":"9","author":"J Piao","year":"2014","unstructured":"Piao J, Shang Y, Liu S, et al. High expression of DEK predicts poor prognosis of gastric adenocarcinoma. Diagn Pathol. 2014;9:67.","journal-title":"Diagn Pathol"},{"issue":"22","key":"1673_CR17","doi-asserted-by":"publisher","first-page":"12234","DOI":"10.3390\/ijms222212234","volume":"22","author":"E Logie","year":"2021","unstructured":"Logie E, Van Puyvelde B, Cuypers B, et al. Ferroptosis induction in multiple myeloma cells triggers DNA methylation and histone modification changes associated with cellular senescence. Int J Mol Sci. 2021;22(22):12234.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1673_CR18","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3390\/cells10020303","volume":"10","author":"A Sacco","year":"2021","unstructured":"Sacco A, Battaglia AM, Botta C, et al. Iron metabolism in the tumor microenvironment-implications for anti-cancer immune response. Cells. 2021;10(2):303.","journal-title":"Cells"},{"issue":"1","key":"1673_CR19","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3390\/cancers12010164","volume":"12","author":"CM Bebber","year":"2020","unstructured":"Bebber CM, Muller F, Prieto Clemente L, et al. Ferroptosis in cancer cell biology. Cancers (Basel). 2020;12(1):164.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"1673_CR20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","volume":"21","author":"C Zhang","year":"2022","unstructured":"Zhang C, Liu X, Jin S, et al. Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol Cancer. 2022;21(1):47.","journal-title":"Mol Cancer"},{"issue":"7","key":"1673_CR21","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.3390\/cancers14071826","volume":"14","author":"D Bekric","year":"2022","unstructured":"Bekric D, Ocker M, Mayr C, et al. Ferroptosis in hepatocellular carcinoma: mechanisms, drug targets and approaches to clinical translation. Cancers (Basel). 2022;14(7):1826.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"1673_CR22","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/2211-5463.12823","volume":"10","author":"Y Wang","year":"2020","unstructured":"Wang Y, Zhao Y, Wang H, et al. Histone demethylase KDM3B protects against ferroptosis by upregulating SLC7A11. FEBS Open Bio. 2020;10(4):637\u201343.","journal-title":"FEBS Open Bio"},{"issue":"4","key":"1673_CR23","doi-asserted-by":"publisher","DOI":"10.1080\/23723556.2015.1054549","volume":"2","author":"Y Yu","year":"2015","unstructured":"Yu Y, Xie Y, Cao L, et al. The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents. Mol Cell Oncol. 2015;2(4): e1054549.","journal-title":"Mol Cell Oncol"},{"key":"1673_CR24","doi-asserted-by":"publisher","first-page":"1203125","DOI":"10.3389\/fphar.2023.1203125","volume":"14","author":"Q Wang","year":"2023","unstructured":"Wang Q, Zhao M, Zhang T, et al. Comprehensive analysis of ferroptosis-related genes in immune infiltration and prognosis in multiple myeloma. Front Pharmacol. 2023;14:1203125.","journal-title":"Front Pharmacol"},{"key":"1673_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2023.109622","volume":"742","author":"W Li","year":"2023","unstructured":"Li W, Fu H, Fang L, et al. Andrographolide induced ferroptosis in multiple myeloma cells by regulating the P38\/Nrf2\/HO-1 pathway. Arch Biochem Biophys. 2023;742: 109622.","journal-title":"Arch Biochem Biophys"},{"issue":"4","key":"1673_CR26","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/s41416-020-01191-y","volume":"124","author":"M Ge","year":"2021","unstructured":"Ge M, Qiao Z, Kong Y, et al. Modulating proteasome inhibitor tolerance in multiple myeloma: an alternative strategy to reverse inevitable resistance. Br J Cancer. 2021;124(4):770\u20136.","journal-title":"Br J Cancer"},{"issue":"5","key":"1673_CR27","doi-asserted-by":"publisher","first-page":"e0178025","DOI":"10.1371\/journal.pone.0178025","volume":"12","author":"ZO \u00c7aliskaner","year":"2017","unstructured":"\u00c7aliskaner ZO, \u00c7akar T, \u00d6z\u00e7elik E, et al. DEK protein level is a biomarker of CD138 normal and malignant plasma cells. PLoS ONE. 2017;12(5):e0178025.","journal-title":"PLoS ONE"},{"issue":"10","key":"1673_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111260","volume":"9","author":"L Lin","year":"2014","unstructured":"Lin L, Piao J, Ma Y, et al. Mechanisms underlying cancer growth and apoptosis by DEK overexpression in colorectal cancer. PLoS ONE. 2014;9(10): e111260.","journal-title":"PLoS ONE"},{"issue":"1","key":"1673_CR29","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.tranon.2017.12.001","volume":"11","author":"T Wise-Draper","year":"2018","unstructured":"Wise-Draper T, Sendilnathan A, Palackdharry S, et al. Decreased plasma DEK oncogene levels correlate with p16-negative disease and advanced tumor stage in a case-control study of patients with head and neck squamous cell carcinoma. Transl Oncol. 2018;11(1):168\u201374.","journal-title":"Transl Oncol"},{"issue":"10","key":"1673_CR30","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.3390\/cancers13102411","volume":"13","author":"M Caillot","year":"2021","unstructured":"Caillot M, Dakik H, Mazurier F, et al. Targeting reactive oxygen species metabolism to induce myeloma cell death. Cancers (Basel). 2021;13(10):2411.","journal-title":"Cancers (Basel)"},{"key":"1673_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100974","volume":"69","author":"Z Zhu","year":"2023","unstructured":"Zhu Z, Shen H, Xu J, et al. GATA3 mediates doxorubicin resistance by inhibiting CYB5R2-catalyzed iron reduction in breast cancer cells. Drug Resist Updat. 2023;69: 100974.","journal-title":"Drug Resist Updat"},{"issue":"1","key":"1673_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12094-021-02669-8","volume":"24","author":"S Li","year":"2022","unstructured":"Li S, Huang Y. Ferroptosis: an iron-dependent cell death form linking metabolism, diseases, immune cell and targeted therapy. Clin Transl Oncol. 2022;24(1):1\u201312.","journal-title":"Clin Transl Oncol"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01673-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-01673-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01673-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T06:45:54Z","timestamp":1764917154000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-01673-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,17]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1673"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-01673-4","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,17]]},"assertion":[{"value":"28 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study received approval from the Clinical Ethics Committee of Shanghai Changzheng Hospital (approval number: 2023SLYS7) prior to its initiation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"252"}}